Iconic Pearl Jam frontman Eddie Vedder has described Pittsburgh’s Clemente Museum as one of his “top five places on the whole ...

Abeona’s deal value is in line with recent voucher sale transactions amid uncertain times in rare disease drug development.

Abeona Therapeutics Inc. (Nasdaq: ABEO), a Cleveland-based biotech company, announced Monday, May 12, that it has entered an ...

The biotech has quickly turned a cell therapy approval into one of the more lucrative recent sales for a priority review ...

Spring has been bountiful at Cleveland's Abeona Therapeutics. | As Abeona gears up for the commercial rollout of Zevaskyn, ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of ...

Epidermolysis Bullosa, also colloquially known as butterfly skin disease, a rare genetic condition that makes your skin very ...

Krystal Biotech, Inc.’s KRYS share price has dipped by 12.19%, which has investors questioning if this is right time to buy.

Shares of Krystal Biotech slid after the company's first-quarter earnings missed Wall Street expectations. The stock was down 14% at $139.03, putting shares 11% in the red for the year.

The ups and downs of their on-screen friendships are what defined the show, and their bonds have crossed over into real life, ...

A Girl Scout troop in Barlow is developing a series of interviews of kids with diseases, disabilities and disorders for a ...